Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology Yr 2 > Pharmacology of diabetes > Flashcards

Pharmacology of diabetes Flashcards

1
Q

Which drugs are used to treat diabetes?

A
  • Metformin
  • Dipeptidyl-peptidase 4 inhibitors
  • Sulphonylurea
  • Sodium-glucose co-transporter inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are examples of Dipeptidyl-peptidase 4 (DPP-4) inhibitors?

A

Sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are examples of sulphonylurea?

A

Gliclazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an example of sodium-glucose co-transporter (SGLT2) inhibitors?

A

Dapaglifozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the drug target for metformin?

A

5′-AMP-activated protein kinase (AMPK) - hepatocyte mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the drug target for sitagliptin?

A

The primary site of DPP-4 inhibitor action is the vascular endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the drug target of sulphonylurea?

A

ATP-sensitive potassium channel

Pancreatic beta cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the drug target for sodium-glucose co-transporter (SGLT2) inhibitors?

A

The primary site of SGLT2 inhibitor action is the proximal convoluted tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action of metformin?

A

Activates AMPK in hepatocyte mitochondria -> inhibits ATP production.
–> Blocks gluconeogenesis and subsequent glucose output
Blocks adenylate cyclase which promotes fat oxidation
Both help to restore insulin sensitivity.



How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the primary mechanism of action of Dipeptidyl-peptidase 4 (DPP-4) inhibitors?

A

Inhibit DDP-4 -> Metabolism of incretins in the plasma.

Incretins (e.g. GLP-1) are secreted by enteroendocrine cells and help stimulate the production of insulin when it is needed and reduce the production of glucagon by the liver when it is not needed
Incretins also slow down digestion and decrease appetite.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the side effects of Metformin?

A

GI side effects (20-30% of patients)

e.g. Abdominal pain, decreased appetite, diarrhoea, vomiting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does metformin cause GI side effects?

A

Metformin is highly polar and requires organic cation transporter-1 (OCT-1) to access tissues. Accumulates in the liver (therapeutic effect) and gastrointestinal tract (side effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When is metformin most effective?

A

In the presence of endogenous insulin so is most effective with some residual functioning pancreatic islet cells



How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the side effect of DDP4 inhibitors?

A

Upper respiratory tract infections (5% of patients) Flu-like symptoms e.g. headache, runny nose, sore throat

Less common but serious:
Serious allergic reactions/ avoid in patients with pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When are DDP-4 I’s effective?

A

When some residual pancreatic beta-cell activity is present.



How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the primary mechanism of action of sulphonylurea?

A

Inhibit the ATP-sensitive potassium (KATP) channel on the pancreatic beta cell. This channel controls beta cell membrane potential. Inhibition causes depolarisation which stimulates Ca2+ influx and subsequent insulin vesicle exocytosis.

17
Q

What is the side effect of sulphonylurea?

A

Weight gain

18
Q

What mitigates weight gain with sulphonylurea?

A

Administration with metformin

19
Q

What is the mechanism of action of SGLT-2 inhibitors?

A

Reversibly inhibits sodium-glucose co-transporter 2 (SGLT2) in the renal proximal convoluted tubule to reduce glucose reabsorption and increase urinary glucose excretion.

20
Q

What are the side effects of SGLT-2 inhibitors?

A

Uro-genital infections due to increased glucose load (5% of patients)

Slight decrease in bone formation

Can worsen diabetic ketoacidosis (stop immediately)

21
Q

What other positive effects can SGLT-2 have?

A

weight loss and a reduction in BP

22
Q

What does SGLT-2 action depend on?

A

normal renal fucntion so they are less effective in patients with renal impairment

23
Q

What is the property of metformin that leads to accumulation in the liver in GI tract?

A

Metformin is highly polar and requires organic cation transporter-1 (OCT-1) to access tissues

24
Q

When are metformin & DDP4is & sulphonylurea most effective?

A

Presence of some residual beta cell activity

25
Q

When is the risk of weight gain mitigated with sulphonylurea?

A

When administered with metformin

26
Q

What is the effect of SGLT2 on weight?

A

Weight loss also causes BP reduction

27
Q

What is SGLT2 action dependent on?

A

Normal renal function

Pharmacology Yr 2 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions